Figure 4
From: S100A12 is a promising biomarker in papillary thyroid cancer
S100A12 knockdown induced PTC cells G0/G1 phase accumulation. (A) Effect of S100A12 silenced on cell cycle progression of the TPC1 and K1 cells, as determined by flow cytometry. (B) Statistical results of flow cytometry.*P < 0.05. (C) Western blot analysis of the expression levels of p-ERK,t-ERK,CyclinD1 and CDK4, in TPC1 and K1, after silencing S100A12.
